| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |